Lucid Diagnostics Inc.
LUCDNasdaqCIK 1799011HealthcareFiscal year ends Dec 31
Reports and events: 111 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-05-1312:21 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-018800 |
| 2024-05-0711:50 ET | 8-K | 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-018020 |
| 2024-05-0221:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-017587 |
| 2024-04-2920:00 ET | DEF 14A | Proxy statementPeriod 2024-04-29 | 0001493152-24-016940 |
| 2024-03-2521:21 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-011161 |
| 2024-03-1412:00 ET | 8-K | 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-24-009895 |
| 2024-02-2021:45 ET | SC 13D/A | Ownership report, active investor, amended | 0001493152-24-007235 |
| 2024-02-0222:11 ET | SC 13D/A | Ownership report, active investor, amended | 0001493152-24-004790 |
| 2024-01-3022:00 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-004345 |
| 2023-11-2821:30 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-23-042922 |
| 2023-11-2421:05 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-23-042669 |
| 2023-11-1402:40 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-040701 |
| 2023-11-1322:15 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001493152-23-040623 |
| 2023-11-1321:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-040556 |
| 2023-10-1813:15 ET | 8-K | 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-23-037572 |
| 2023-08-1420:45 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001493152-23-028577 |
| 2023-06-2121:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-23-022033 |
| 2023-05-1520:25 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001493152-23-017413 |
| 2023-05-0113:00 ET | DEF 14A | Proxy statementPeriod 2023-05-01 | 0001493152-23-014873 |
| 2023-04-0313:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-010538 |
| 2023-03-2421:17 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001493152-23-008932 |
| 2023-03-1421:00 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-007624 |
| 2023-03-1422:36 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001493152-23-007482 |
| 2023-03-1321:00 ET | 8-K | 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-23-007447 |
| 2023-02-1721:30 ET | 8-K | 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-005454 |
| 2023-02-1621:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-005331 |
| 2023-01-1813:36 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-001724 |
| 2022-12-0222:22 ET | SC 13D/A | Ownership report, active investor, amended | 0001493152-22-034357 |
| 2022-12-0222:20 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-22-034355 |
| 2022-11-1422:23 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-032281 |
| 2022-11-1421:08 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001493152-22-032029 |
| 2022-08-1522:11 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001493152-22-023043 |
| 2022-08-1522:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-023035 |
| 2022-08-0220:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-22-021012 |
| 2022-07-1400:21 ET | S-1/A | Registration statement, amended | 0001493152-22-019227 |
| 2022-06-2213:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-22-017443 |
| 2022-06-1723:31 ET | S-1 | Registration statement | 0001493152-22-017026 |
| 2022-05-1621:18 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001493152-22-013957 |
| 2022-05-1221:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-013085 |
| 2022-05-0920:47 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-012574 |
| 2022-05-0213:25 ET | DEF 14A | Proxy statementPeriod 2022-05-02 | 0001493152-22-011734 |
| 2022-04-0601:21 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001493152-22-009199 |
| 2022-04-0522:28 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-009074 |
| 2022-04-0120:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-22-008837 |
| 2022-03-2921:25 ET | 8-K/A | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-008068 |
| 2022-03-2821:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-007908 |
| 2022-03-2320:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-22-007547 |
| 2022-03-0713:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-006152 |
| 2022-03-0313:26 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-005892 |
| 2022-01-2021:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-22-001725 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.